Watchlist Price Alert

Reviva Pharmaceuticals I... (RVPHW)

NASDAQ: RVPHW · Real-Time Price · USD

0.05

-0.01 (-10.39%)

At close: May 13, 2025, 3:52 PM

Reviva Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Feb 29, 2020	Feb 28, 2019
Net Income	-29.92M	-39.26M	-24.34M	-8.52M	-3.78M	-846.83K	-1.68M
Depreciation & Amortization	n/a	n/a	n/a	n/a	591.00	645.00	17.72K
Stock-Based Compensation	1.63M	3.41M	176.74K	106.71K	n/a	n/a	21.05K
Other Working Capital	-6.83M	6.96M	2M	-203.71K	-3.1M	475.98K	541.98K
Other Non-Cash Items	-717.64K	239.22K	194.71K	-1.55M	2.39M	-6.41K	28.24K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-4.54M	7.28M	5.01M	-702.17K	-2.33M	634.15K	541.98K
Operating Cash Flow	-33.54M	-28.32M	-18.96M	-10.67M	-3.73M	-218.44K	-1.07M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	458.15K	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	5.68M	18.97K	98.48K	12.83M	n/a	175K
Financial Cash Flow	23.65M	33.17M	7.79M	31.6M	12.83M	100K	175K
Net Cash Flow	-9.89M	4.85M	-11.17M	20.93M	8.76M	-118.44K	118.64K
Free Cash Flow	-33.54M	-28.32M	-18.96M	-10.67M	-3.73M	-218.44K	-1.07M